Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04330235 · ClinicalTrials.gov registry record
Evaluating a Healthy Restaurant Kids Meals Policy
A clinical trial, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- 3,480
- Enrollment target
NCT04330235: Completed study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT04330235 is a clinical trial that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 3,480 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04330235 has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- 3,480 participants
- Enrollment target
Study Summary
More than a dozen municipalities have passed healthy default kids' beverage policies. These policies seek to reduce child consumption of sugar-sweetened beverages (SSBs) by requiring that restaurants serve only healthy beverages (e.g., water, milk, or 100% juice) instead of SSBs as the default choice with children's meals in restaurants. These policies have potential to meaningfully reduce child SSB consumption. However, there are significant gaps in our knowledge of the effects of healthy default beverage policies on children's health. This study uses a natural experiment to evaluate the effects of a healthy default beverage policy in two U.S. cities, New York City and Philadelphia, on children's fast-food restaurant meal orders and dietary intake. The primary hypothesis is that the policy will reduce children's SSB purchases and consumption, reduce children's total caloric intake, and improve diet quality at the fast-food restaurant meal and on the day of the restaurant meal.
Primary Outcome
Total calories consumed by the child on the day of the restaurant meal
Interventions
- OTHER Healthy Default Kids' Beverage Policy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,480 participants |
| Start Date | 2019-10-13 |
| Est. Completion | 2022-07-18 |
What the finished NCT04330235 record still lists
NCT04330235 is an observational study that tracks outcomes without assigning an intervention. Its 3,480 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Healthy Default Kids' Beverage Policy is the first listed.
NCT04330235 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04330235 about?
NCT04330235 is a clinical study titled "Evaluating a Healthy Restaurant Kids Meals Policy". More than a dozen municipalities have passed healthy default kids' beverage policies. These policies seek to reduce child consumption of sugar-sweetened beverages (SSBs) by requiring that restaurants serve only healthy beverages (e.g., water, milk, or 100% juice) instead of SSBs as the default choic...
What is the current status of trial NCT04330235?
This trial is currently completed. The enrollment target is 3,480 participants. The study started on 2019-10-13. Estimated completion is 2022-07-18.
What interventions are being tested in trial NCT04330235?
The interventions under investigation include: Healthy Default Kids' Beverage Policy (OTHER).
Who is sponsoring clinical trial NCT04330235?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI